Reference number : 276-2020-2021-Q2-00381, amendment number : , agreement type : C, recipient legal name : Phycus Biotechnologies Inc.|Phycus Biotechnologies Inc., recipient country : CA, recipient province : NS, recipient city : Sydney|Sydney, recipient postal code : B1P 6L2, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion et productivité des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 216711, agreement title french : 216711, agreement number : 216711, agreement value : 400000.0, agreement start date : 2020-08-30, agreement end date : 2021-07-31, description english : Advance technology to produce bio-based glycolic acid on a commercial scale, description french : Advance technology to produce bio-based glycolic acid on a commercial scale, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution. The total government funding is $500,000.00., additional information french : Le type d'aide est contribution à remboursement inconditionnel. Le financement gouvernemental total est 500 000,00 $., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique